Blue Trust Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Blue Trust Inc's BMY Position: Q2 2026 in Review
Blue Trust Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.02% in Q2 2026, selling an estimated $172 and leaving 16,168 shares worth $932K. The position accounts for 0.01% of the portfolio, ranked #313.
Blue Trust Inc first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.48M in Q1 2023. 938 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Blue Trust Inc held 16,168 shares of Bristol-Myers Squibb worth $932K as of Q2 2026.
- Blue Trust Inc sold 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
- Bristol-Myers Squibb made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #313 holding.
- Blue Trust Inc first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
- Blue Trust Inc's Bristol-Myers Squibb position peaked at $1.48M in Q1 2023.
- 938 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.